Furthermore, our drug response prediction analysis identified several chemotherapeutic agents, including Nutlin‐3a, Dactolisib and Rapamycin, potentially more effective in STAD tumours with high IGFBP7 expression. This evidence concerns the gene IGFBP7 and neoplasm.